Skip to content
    Oxford Science Enterprises logo

    Oxford Science Enterprises

    Oxford, United KingdomFounded 2015

    Oxford Science Enterprises (OSE) is an independent venture capital firm that partners with the University of Oxford to found, fund, and build transformational businesses based on university research across life sciences, health tech, and deep technology. Originally established as Oxford Sciences Innovation, it was rebranded to Oxford Science Enterprises.

    Deal activity increased 140% year-over-year (12 deals in the last 12 months). Average disclosed round size is $39.9M (across 86 rounds with reported amounts).

    Find people at Oxford Science Enterprises on Goldilocks AI

    Portfolio

    95

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    12

    Team

    Claire Brown

    Claire Brown

    Partner, Life Sciences

    Craig Fox

    Craig Fox

    Operating Partner, Life Sciences

    Heather Roxborough

    Heather Roxborough

    Senior Partner, Head of HealthTech

    Joel Schoppig

    Joel Schoppig

    Partner, HealthTech

    Katherine Ward

    Katherine Ward

    Operating Partner, HealthTech

    Katya Smirnyagina

    Katya Smirnyagina

    Senior Partner, Head of Life Sciences

    Lilly Bussmann

    Lilly Bussmann

    Partner

    Nick Dixon-Clegg

    Nick Dixon-Clegg

    Partner, Head of Independent Investments

    Oliver Mahony

    Oliver Mahony

    Partner, Independent Investments

    Polly Elvin

    Polly Elvin

    Partner, Capital Formation & Investor Relations

    Sam Harman

    Sam Harman

    Partner, Head of Deep Tech

    Sanne De Jongh

    Sanne De Jongh

    Partner, Life Sciences

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    143 investments
    CompanyRoundAmountDate
    Salience Labs logoSalience LabsSeed—Sep 2026
    Fractile logoFractileSeries B$220MSep 2026
    RQ Biotechnology logoRQ BiotechnologySeries A$115MJun 2026
    Oxford Quantum Circuits logoOxford Quantum CircuitsSeries C—Jun 2026
    Quantum Motion logoQuantum MotionSeries B—May 2026
    Fractile logoFractileSeries D—Mar 2026
    SStatefulPre-Seed$4.8MMar 2026
    AAllosSeed$5MJan 2026
    Beacon Therapeutics logoBeacon TherapeuticsSeries C—Jan 2026
    RQ Biotechnology logoRQ BiotechnologySeries A$115MJan 2026
    Fractile logoFractileSeries A$22.5MJan 2026
    Oxford Quantum Circuits logoOxford Quantum CircuitsSeries C—Jan 2026
    Densix logoDensixSeed$4MJan 2026
    Allos AI logoAllos AISeed$5MJan 2026
    Mirae Health logoMirae HealthUnknown$5.4MJan 2026
    Quantum Motion logoQuantum MotionSeries C$160MJan 2026
    Scripta Therapeutics logoScripta TherapeuticsSeed$12MNov 2025
    Scripta logoScriptaSeed$12MNov 2025
    Valink Therapeutics logoValink TherapeuticsSeries A$11.8MOct 2025
    Wild Bioscience logoWild BioscienceSeries A—Oct 2025
    Kneu Health logoKneu HealthSeed$5.6MOct 2025
    Ultromics logoUltromicsSeries C$55MJul 2025
    Mode Labs logoMode LabsSeed—May 2025
    Mixergy logoMixergyUnknown$15.2MMar 2025
    Salience Labs logoSalience LabsSeries A$30MFeb 2025
    Page 1 of 6

    Top Co-Investors

    Last updated: 7 October 2026